Why Bill Gates is betting on a start-up that prints synthetic DNA – CNBC
CNBC |
Why Bill Gates is betting on a start-up that prints synthetic DNA
CNBC In 2014, Ginkgo Bioworks entered Y Combinator as the first biotech company ever accepted by the famed accelerator. Four years later the Boston-based synthetic biology start-up, founded by a team of MIT scientists in 2009, has raised $429 million … |
